Aside from Humana and Kaiser Permanente Ventures, Omada Health has scored yet another insurer investor: Cigna.
Omada, which has a built a digital platform to prevent prediabetics from becoming full-blown Type 2 diabetes patients, announced Wednesday that Cigna led its $50 million round that also attracted two new investors: Civilization Ventures and Sanofi Genzyme BioVentures.
Cigna is doing more than just investing in Omada. It is also expanding its commercial partnership with the San Francisco-based company such that the behavioral health technology will be made available to Cigna customers with prediabetes, as well as those at higher risk of chronic conditions such as heart disease and hypertension.
Read More: http://medcitynews.com/2017/06/cigna-leads-omada-healths-latest-50m-investment-round/